Phase 1 HFpEF Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

Heart Failure With Preserved Ejection Fraction (HFpEF)Heart

Vasa Therapeutics42 enrolled21 locationsNCT07219511

Recruiting

Phase 1Phase 2

Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

HFpEF - Heart Failure With Preserved Ejection FractionColchicine

I.M. Sechenov First Moscow State Medical University40 enrolled2 locationsNCT05637398

Recruiting

Phase 1

Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

Heart Failure With Preserved Ejection Fraction (HFpEF)

Secretome Therapeutics12 enrolled2 locationsNCT06560762